VEGFD regulates blood vascular development by modulating SOX18 activity

Blood

Volumn 123, Issue 7, 2014, Pages 1102-1112

  Duong, Tam ^a   Koltowska, Katarzyna ^a   Pichol Thievend, Cathy ^a   Le Guen, Ludovic ^a   Fontaine, Frank ^a   Smith, Kelly A ^a   Truong, Vy ^a   Skoczylas, Renae ^a   Stacker, Steven A ^b,c   Achen, Marc G ^b,c   Koopman, Peter ^a   Hogan, Benjamin M ^a   Francois, Mathias ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; TRANSCRIPTION FACTOR SOX18; TRANSCRIPTION FACTOR SOX7; VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; SOX18 PROTEIN, ZEBRAFISH; TRANSCRIPTION FACTOR SOX; ZEBRAFISH PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE INTERACTION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; BLOOD VESSEL; C57BL MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PRENATAL DEVELOPMENT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD VESSELS; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; SOXF TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR D; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84898794273     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-495432     Document Type: Article

References (57)

1. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380(6573):435-439. (Pubitemid 26102719)
2. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380(6573):439-442. (Pubitemid 26102720)
3. Patel-Hett S, D'Amore PA. Signal transduction in vasculogenesis and developmental angiogenesis. Int J Dev Biol. 2011;55(4-5):353-363.
4. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990;50(6):1774-1778. (Pubitemid 20098819)
5. Bahary N, Goishi K, Stuckenholz C, et al. Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood. 2007;110(10):3627-3636. (Pubitemid 350159631)
6. Herbert SP, Huisken J, Kim TN, et al. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science. 2009;326(5950):294-298.
7. Bellomo D, Headrick JP, Silins GU, et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 2000;86(2):E29-E35.
8. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74-80. (Pubitemid 38081471)
9. Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA. 1998;95(2):548-553. (Pubitemid 28083780)
10. Baldwin ME, Catimel B, Nice EC, et al. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem. 2001;276(22):19166-19171.
11. Koch M, Dettori D, Van Nuffelen A, et al. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J Pathol. 2009;219(3):356-364.
12. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med. 2001;7(2):186-191. (Pubitemid 32148485)
13. Von Marschall Z, Scholz A, Stacker SA, et al. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol. 2005;27(3):669-679.
14. Heikura T, Nieminen T, Roschier MM, et al. Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle. J Gene Med. 2012;14(1):35-43.
15. Song M, Yang H, Yao S, et al. A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis. Biochem Biophys Res Commun. 2007;357(4):924-930. (Pubitemid 46711086)
16. Baldwin ME, Halford MM, Roufail S, et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol. 2005;25(6):2441-2449. (Pubitemid 40354637)
17. Haiko P, Makinen T, Keskitalo S, et al. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol. 2008;28(15):4843-4850.
18. Hosking BM, Muscat GE, Koopman PA, Dowhan DH, Dunn TL. Trans-activation and DNA-binding properties of the transcription factor, Sox-18. Nucleic Acids Res. 1995;23(14):2626-2628.
19. Herpers R, van de Kamp E, Duckers HJ, Schulte-Merker S. Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish. Circ Res. 2008;102(1):12-15.
20. Cermenati S, Moleri S, Cimbro S, et al. Sox18 and Sox7 play redundant roles in vascular development. Blood. 2008;111(5):2657-2666.
21. Pendeville H, Winandy M, Manfroid I, et al. Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Dev Biol. 2008;317(2):405-416.
22. Downes M, Koopman P. SOX18 and the transcriptional regulation of blood vessel development. Trends Cardiovasc Med. 2001;11(8):318-324. (Pubitemid 33116304)
23. Hosking B, François M, Wilhelm D, et al. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development. 2009;136(14):2385-2391.
24. Irrthum A, Devriendt K, Chitayat D, et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis- lymphedema-telangiectasia. Am J Hum Genet. 2003;72(6):1470-1478. (Pubitemid 36628386)
25. Hogan BM, Bos FL, Bussmann J, et al. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet. 2009;41(4):396-398.
26. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248(2):307-318. (Pubitemid 35002091)
27. Chi NC, Shaw RM, De Val S, et al. Foxn4 directly regulates tbx2b expression and atrioventricular canal formation. Genes Dev. 2008;22(6):734-739. (Pubitemid 351439104)
28. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development. 2005;132(23):5199-5209. (Pubitemid 43020175)
29. Hogan BM, Herpers R, Witte M, et al. Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development. 2009;136(23):4001-4009.
30. Ober EA, Olofsson B, Mäkinen T, et al. Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep. 2004;5(1):78-84. (Pubitemid 38228532)
31. Covassin LD, Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND. Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA. 2006;103(17):6554-6559.
32. Wiley DM, Kim JD, Hao J, Hong CC, Bautch VL, Jin SW. Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol. 2011;13(6):686-692.
33. Serbedzija GN, Flynn E, Willett CE. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis. 1999;3(4):353-359. (Pubitemid 129643978)
34. Hong CC, Peterson QP, Hong JY, Peterson RT. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol. 2006;16(13):1366-1372. (Pubitemid 43975369)
35. Deng Y, Atri D, Eichmann A, Simons M. Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest. 2013;123(3):1202-1215.
36. Thisse C, Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 2008;3(1):59-69.
37. Durbin L, Brennan C, Shiomi K, et al. Eph signaling is required for segmentation and differentiation of the somites. Genes Dev. 1998;12(19):3096- 3109. (Pubitemid 28469310)
38. Song HD, Sun XJ, Deng M, et al. Hematopoietic gene expression profile in zebrafish kidney marrow. Proc Natl Acad Sci USA. 2004;101(46):16240-16245. (Pubitemid 39552829)
39. Thompson MA, Ransom DG, Pratt SJ, et al. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol. 1998;197(2):248-269. (Pubitemid 28265456)
40. Sumanas S, Jorniak T, Lin S. Identification of novel vascular endothelial-specific genes by the microarray analysis of the zebrafish cloche mutants. Blood. 2005;106(2):534-541. (Pubitemid 40981248)
41. Chan TM, Chao CH, Wang HD, Yu YJ, Yuh CH. Functional analysis of the evolutionarily conserved cis-regulatory elements on the sox17 gene in zebrafish. Dev Biol. 2009;326(2):456-470.
42. Lawson ND, Mugford JW, Diamond BA, Weinstein BM. phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev. 2003;17(11):1346-1351. (Pubitemid 36666004)
43. Kohli V, Schumacher JA, Desai SP, Rehn K, Sumanas S. Arterial and venous progenitors of the major axial vessels originate at distinct locations. Dev Cell. 2013;25(2):196-206.
44. Kanai-Azuma M, Kanai Y, Gad JM, et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development. 2002;129(10):2367-2379. (Pubitemid 34863845)
45. Pennisi D, Bowles J, Nagy A, Muscat G, Koopman P. Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol. 2000;20(24):9331-9336. (Pubitemid 32246117)
46. François M, Caprini A, Hosking B, et al. Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008;456(7222):643-647.
47. James JM, Nalbandian A, Mukouyama YS. TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin. Development. 2013;140(18):3903-3914.
48. Pennisi D, Gardner J, Chambers D, et al. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet. 2000;24(4):434-437. (Pubitemid 30187448)
49. Rebhun RB, Langley RR, Yokoi K, Fan D, Gershenwald JE, Fidler IJ. Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. Neoplasia. 2006;8(9):747-757. (Pubitemid 44465526)
50. Hosking BM, Wang SC, Downes M, Koopman P, Muscat GE. The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18. J Biol Chem. 2004;279(7):5314-5322. (Pubitemid 38220552)
51. Downes M, François M, Ferguson C, Parton RG, Koopman P. Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation. Hum Mol Genet. 2009;18(15):2839-2850.
52. Hoeth M, Niederleithner H, Hofer-Warbinek R, et al. The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells. PLoS ONE. 2012;7(1):e30982.
53. Choi J, Dong L, Ahn J, Dao D, Hammerschmidt M, Chen JN. FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafish. Dev Biol. 2007;304(2):735-744. (Pubitemid 46527576)
54. Genzer MA, Bridgewater LCA. A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res. 2007;35(4):1178-1186. (Pubitemid 46522971)
55. Peirano RI, Wegner M. The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 2000;28(16):3047-3055. (Pubitemid 30624094)
56. Kim J, Felts S, Llauger L, et al. Development of a fluorescence polarization assay for the molecular chaperone Hsp90. J Biomol Screen. 2004;9(5):375-381.
57. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet. 2001;2(3):165-174. (Pubitemid 33674015)